CETUXIMAB
- UNII: PQX0D8J21J
- Preferred Substance Name: CETUXIMAB
- 205923-56-4
- ABP-494
- C225
- C-225
- CETUXIMAB (GENETICAL RECOMBINATION)
- CETUXIMAB (GENETICAL RECOMBINATION) [JAN]
- CETUXIMAB [EMA EPAR]
- CETUXIMAB [HSDB]
- CETUXIMAB [INN]
- CETUXIMAB [JAN]
- CETUXIMAB [MART.]
- CETUXIMAB [MI]
- CETUXIMAB [PURPLE BOOK CDER]
- CETUXIMAB [USAN]
- CETUXIMAB [VANDF]
- CETUXIMAB [WHO-DD]
- CETUXIMAB BETA
- CETUXIMAB BETA [INN]
- CETUXIMAB BIOSIMILAR (ABP-494)
- CETUXIMAB BIOSIMILAR (SHANGHAI ZHANGJIANG)
- CMAB009
- CMAB-009
- CMAB-009 (BIOSIMILAR OF CETUXIMAB)
- ERBITUX
- EXTRACELLULAR DOMAIN HUMAN EGFR BINDING RECOMBINANT, HUMAN/MOUSE CHIMERIC MONOCLONAL ANTIBODY
- FV REGIONS OF MURINE ANTI-EGFR ANTIBODY WITH HUMAN IGG1 HEAVY AND KAPPA LIGHT CHAIN CONSTANT REGIONS, MW 152000
- IMC-225
- IMCC225
- IMCC-225
- IMC-C225
- IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
- IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
- IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
- IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
- MOAB C225
About, Contact Us, Copyright, Privacy, Accessibility
U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002
U.S. Food and Drug Administration, Health & Human Services
Powered by
